Oracle’s stock performance from the 1980s pushed the tech giant to split its shares. Its fortunes rose and fell during the ...

The last time the semiconductor initiated a stock repurchase program was in 2018; here’s what its ongoing buybacks mean for ...

The chief development officer of Corcept Therapeutics sold 20,000 shares of the biotech for $703,656 on Tuesday. The transaction was executed as a direct open-market sale of option shares; no indirect ...

Trent shares fell sharply on Tuesday, erasing nearly Rs 18,000 crore in market value, after its Q1 revenue growth of 19% ...